BR112013009260A2 - compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase - Google Patents
compostos de carboxamida de piridazina substituídos como compostos inibidores de quinaseInfo
- Publication number
- BR112013009260A2 BR112013009260A2 BR112013009260A BR112013009260A BR112013009260A2 BR 112013009260 A2 BR112013009260 A2 BR 112013009260A2 BR 112013009260 A BR112013009260 A BR 112013009260A BR 112013009260 A BR112013009260 A BR 112013009260A BR 112013009260 A2 BR112013009260 A2 BR 112013009260A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- kinase inhibitor
- substituted pyridazine
- pyridazine carboxamide
- inhibitor compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Abstract
compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase. os novos derivados de piridazina têm propriedades de drogas inesperadas como inibidores de proteínas quinase, especialmente contra c-met e são úteis no tratamento de distúrbios relacionados com as atividades da proteína quinase anormais, como o câncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39146410P | 2010-10-08 | 2010-10-08 | |
PCT/US2011/055427 WO2012048258A2 (en) | 2010-10-08 | 2011-10-07 | Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013009260A2 true BR112013009260A2 (pt) | 2016-07-26 |
Family
ID=45928472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013009260A BR112013009260A2 (pt) | 2010-10-08 | 2011-10-07 | compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase |
Country Status (10)
Country | Link |
---|---|
US (1) | US9242958B2 (pt) |
EP (1) | EP2625173A4 (pt) |
JP (2) | JP5909236B2 (pt) |
KR (1) | KR20130139987A (pt) |
CN (1) | CN103298803A (pt) |
AU (2) | AU2011311813A1 (pt) |
BR (1) | BR112013009260A2 (pt) |
CA (1) | CA2813580C (pt) |
EA (1) | EA025030B1 (pt) |
WO (1) | WO2012048258A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6023062B2 (ja) * | 2010-10-08 | 2016-11-09 | エックスカバリー ホールディング カンパニー エルエルシー | 置換ピリダジンカルボキサミド化合物 |
WO2015123453A1 (en) * | 2014-02-14 | 2015-08-20 | Portola Pharmaceuticals, Inc. | Pyridazine compounds as jak inhibitors |
TWI646094B (zh) * | 2016-06-01 | 2019-01-01 | 大陸商貝達藥業股份有限公司 | Crystal form of inhibitory protein kinase active compound and application thereof |
CN114364798A (zh) | 2019-03-21 | 2022-04-15 | 欧恩科斯欧公司 | 用于治疗癌症的Dbait分子与激酶抑制剂的组合 |
AU2020378630A1 (en) | 2019-11-08 | 2022-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008510792A (ja) * | 2004-08-26 | 2008-04-10 | ファイザー・インク | タンパク質チロシンキナーゼ阻害剤としてのアミノヘテロアリール化合物 |
KR20080059625A (ko) * | 2005-10-04 | 2008-06-30 | 칼 짜이스 에스엠테 아게 | 리소그래피 장치 및 제어 방법 |
US8551995B2 (en) * | 2007-01-19 | 2013-10-08 | Xcovery Holding Company, Llc | Kinase inhibitor compounds |
BRPI0914305B8 (pt) * | 2008-06-19 | 2021-05-25 | Xcovery Holding Co Llc | compostos de piridazina carboxamida substituída como compostos inibidores da quinase, uso dos compostos e uso de uma composição compreendendo os compostos |
-
2011
- 2011-10-07 AU AU2011311813A patent/AU2011311813A1/en not_active Abandoned
- 2011-10-07 WO PCT/US2011/055427 patent/WO2012048258A2/en active Application Filing
- 2011-10-07 EP EP11831701.5A patent/EP2625173A4/en not_active Withdrawn
- 2011-10-07 US US13/877,812 patent/US9242958B2/en not_active Expired - Fee Related
- 2011-10-07 EA EA201390519A patent/EA025030B1/ru not_active IP Right Cessation
- 2011-10-07 CN CN2011800575145A patent/CN103298803A/zh active Pending
- 2011-10-07 BR BR112013009260A patent/BR112013009260A2/pt not_active IP Right Cessation
- 2011-10-07 CA CA2813580A patent/CA2813580C/en active Active
- 2011-10-07 KR KR1020137011875A patent/KR20130139987A/ko not_active Application Discontinuation
- 2011-10-07 JP JP2013532984A patent/JP5909236B2/ja not_active Expired - Fee Related
-
2016
- 2016-03-25 JP JP2016061902A patent/JP2016155841A/ja active Pending
- 2016-11-21 AU AU2016262642A patent/AU2016262642A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2813580C (en) | 2017-12-05 |
EA025030B1 (ru) | 2016-11-30 |
EP2625173A4 (en) | 2014-03-26 |
US9242958B2 (en) | 2016-01-26 |
KR20130139987A (ko) | 2013-12-23 |
WO2012048258A2 (en) | 2012-04-12 |
JP2013539764A (ja) | 2013-10-28 |
JP2016155841A (ja) | 2016-09-01 |
EA201390519A1 (ru) | 2013-09-30 |
CN103298803A (zh) | 2013-09-11 |
WO2012048258A3 (en) | 2012-06-28 |
AU2016262642A1 (en) | 2016-12-08 |
AU2011311813A1 (en) | 2013-05-02 |
CA2813580A1 (en) | 2012-04-12 |
JP5909236B2 (ja) | 2016-04-26 |
EP2625173A2 (en) | 2013-08-14 |
US20130203763A1 (en) | 2013-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018236800B2 (en) | DNA-PK inhibitors | |
PH12019502809A1 (en) | Substituted tricyclic compounds as fgfr inhibitors | |
CY1122098T1 (el) | Παραγωγα ισοχρωμενιου ως αναστολεις κινασων φωσφοϊνοσιτιδης-3 | |
EA201391390A1 (ru) | Циклопропиламины в качестве ингибиторов lsd | |
TN2013000348A1 (en) | Compounds and compositions as trk inhibitors | |
MY167245A (en) | Compounds and compositions as c-kit kinase inhibitors | |
BRPI0914305B8 (pt) | compostos de piridazina carboxamida substituída como compostos inibidores da quinase, uso dos compostos e uso de uma composição compreendendo os compostos | |
EA023222B8 (ru) | Пиразолилхиноксалиновые ингибиторы киназы | |
MX339937B (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit. | |
EA201200473A1 (ru) | Замещенные (гетероарилметил)тиогидантоины | |
MX362215B (es) | Derivados 2-aminopirido-[4,3-d]pirimidin-5-ona y su uso como inhibidores de wee-1. | |
MX2009011951A (es) | Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
MX2010009207A (es) | Compuestos y composiciones heterociclicos como inhibidores de c-kit y pdgfr cinasa. | |
MX2014002486A (es) | Compuestos y composiciones como inhibidores de cinasa pdgfr. | |
BRPI0811617A2 (pt) | derivados de primidina e composições como inibidores de c-kit e pdgfr quinase. | |
NZ709153A (en) | Pyrimidinone derivatives having human neutrophil elastase inhibitory activity | |
UA112795C2 (uk) | Біциклічні піразинонові похідні | |
IN2015DN01151A (pt) | ||
WO2012048259A3 (en) | Substituted pyridazine carboxamide compounds | |
MX2009011952A (es) | Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
BR112013009260A2 (pt) | compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase | |
MX2012012031A (es) | Inhibidores de la actividad de la proteina tirosina quinasa y uso de los mismos para tratar transtornos oftalmicos. | |
MX2012013527A (es) | Quinazolinas policíclicas, preparación de las mismas, y uso de las mismas. | |
AU2016204389A1 (en) | Kinase inhibitors for the treatment of cancer | |
WO2014038881A3 (ko) | 피리돈 유도체를 포함하는 단백질 키나제 억제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2534 DE 30-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |